Ranked by engagement
Top topics — all time page 12
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 12 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Triple agonism: additive, synergistic, or neither?
The question in the title: Triple agonism: additive, synergistic, or neither? I will give what I have already checked below so nobody repeats it. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
|
+71 | 80 | 38k | 11mo |
|
Dead volume across syringe and needle combinations
On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go wrong…
|
+72 | 80 | 28k | 5mo |
|
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
|
+97 | 104 | 15k | 3mo |
|
Muscle cramps: the ordinary causes before the exotic ones — a second dataset
Posting this under the heading it deserves: Muscle cramps: the ordinary causes before the exotic ones — a second dataset Everything below is what sits behind that. Reporting something rather than asking about…
|
+65 | 77 | 39k | 1d |
|
Reconstitution volumes that produce round numbers, tabulated
Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly…
|
+103 | 112 | 1.7k | 3mo |
|
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in…
|
+107 | 111 | 12k | 1d |
|
Second pass at: Pen dose counters: what a click does and does not guarantee
Second pass at: Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been…
|
+63 | 68 | 51k | 13mo |
|
Payment mechanics and the recovery options that do not exist
Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
|
+80 | 89 | 24k | 9mo |
|
Blind submission and why it changes minds
Blind submission and why it changes minds — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+91 | 96 | 1.1k | 21mo |
|
Why retatrutide discussion here is more cautious than elsewhere — one year on
Asking directly, because I could not find a straight answer: Why retatrutide discussion here is more cautious than elsewhere — one year on Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it…
|
+92 | 97 | 3.6k | 20h |
|
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem
On the subject in the title: Lateral-flow and colorimetric approaches: the specificity problem Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+77 | 89 | 16k | 9h |
|
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting;…
|
+84 | 91 | 18k | 2y |
|
The most useful thing you learned here that was not the answer you came for
The most useful thing you learned here that was not the answer you came for Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still…
|
+54 | 61 | 57k | 1d |
|
[2026 update] Does dual agonism explain the effect size, or is it dose?
Asking directly, because I could not find a straight answer: Does dual agonism explain the effect size, or is it dose? Session topic: SELECT ( N Engl J Med , 2023). Please read it before posting; the…
|
+58 | 63 | 40k | 9mo |
|
[2026 update] A rising related-substance total over six months: degradation or method drift?
The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody repeats it. Posting the method first, because…
|
+71 | 78 | 34k | 5mo |
|
Meeting a protein target on a suppressed appetite — does this still hold?
Asking directly, because I could not find a straight answer: Meeting a protein target on a suppressed appetite — does this still hold? Longitudinal report with the method stated, because a number without a…
|
+56 | 61 | 45k | 19mo |
|
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes
The SOUL trial and oral semaglutide cardiovascular outcomes — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+100 | 104 | 4.2k | 5mo |
|
Documenting a supplier's response to a discrepancy — does this still hold?
Documenting a supplier's response to a discrepancy — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…
|
+47 | 52 | 58k | 16mo |
|
Endotoxin and why it is a separate question from purity — what changed since
On the subject in the title: Endotoxin and why it is a separate question from purity — what changed since Working notes rather than a conclusion. A documentation question rather than an analytical one. I have…
|
+78 | 91 | 1k | 10h |
|
Second pass at: How to ask a question when you cannot say why you are asking it
Second pass at: How to ask a question when you cannot say why you are asking it — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to…
|
+73 | 81 | 16k | 4mo |
|
Revisiting: Protein density versus volume when you cannot eat much
Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+97 | 108 | 3.6k | 2d |
|
Measurement error in home scales, with a worked standard deviation — the long version
On the subject in the title: Measurement error in home scales, with a worked standard deviation — the long version Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022).…
|
+96 | 105 | 2k | 2mo |
|
How to ask about something you suspect is a bad idea
The question in the title: How to ask about something you suspect is a bad idea I will give what I have already checked below so nobody repeats it. Question in the title. Context below, and I have tried to…
|
+81 | 87 | 16k | 2mo |
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
|
+85 | 92 | 5.5k | 11mo |
|
Personal or family history of medullary thyroid carcinoma — what changed since
Posting this under the heading it deserves: Personal or family history of medullary thyroid carcinoma — what changed since Everything below is what sits behind that. Asking about a population rather than…
|
+91 | 96 | 1.3k | 25d |
|
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version
On the subject in the title: Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med ,…
|
+85 | 90 | 13k | 7mo |
|
[2026 update] How much of the diluent volume the powder itself displaces
The question in the title: How much of the diluent volume the powder itself displaces I will give what I have already checked below so nobody repeats it. Practical question with the units stated, because I…
|
+89 | 100 | 3.2k | 8mo |
|
Airline travel with a temperature-sensitive injectable — what changed since
Airline travel with a temperature-sensitive injectable — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+89 | 95 | 5.3k | 9mo |
|
Second pass at: Programming during a large energy deficit
On the subject in the title: Second pass at: Programming during a large energy deficit Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is…
|
+94 | 100 | 1.2k | 8mo |
|
Seven-day rolling means and why weekly readings mislead — one year on
On the subject in the title: Seven-day rolling means and why weekly readings mislead — one year on Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without…
|
+78 | 88 | 16k | 5mo |